Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

Clinical trial NCT00558259 · COMPLETED

Trial details

NCT number: NCT00558259
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Venous Thromboembolism

Start date: 2007-11-01
Primary completion: 2011-02-01
Enrollment: 1353

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.